HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615 | -60.7% | 16,088 | -62.9% | 0.01% | -57.6% |
| Q2 2023 | $1,563 | -5.6% | 43,326 | 0.0% | 0.03% | -5.7% |
| Q1 2023 | $1,655 | -32.9% | 43,326 | 0.0% | 0.04% | -36.4% |
| Q4 2022 | $2,465 | -99.9% | 43,326 | 0.0% | 0.06% | +34.1% |
| Q3 2022 | $1,713,000 | -10.1% | 43,326 | 0.0% | 0.04% | -4.7% |
| Q2 2022 | $1,906,000 | +10.3% | 43,326 | 0.0% | 0.04% | +26.5% |
| Q1 2022 | $1,728,000 | -40.4% | 43,326 | -39.9% | 0.03% | -29.2% |
| Q4 2021 | $2,900,000 | -1.2% | 72,126 | 0.0% | 0.05% | -9.4% |
| Q3 2021 | $2,934,000 | -10.4% | 72,126 | 0.0% | 0.05% | -8.6% |
| Q2 2021 | $3,275,000 | +41.2% | 72,126 | +29.7% | 0.06% | +48.7% |
| Q1 2021 | $2,319,000 | – | 55,626 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |